Related Experiment Video
Updated: Apr 17, 2026

07:06
Isolation and Characterization of Mesenchymal Stromal Cells from Human Umbilical Cord and Fetal Placenta
Published on: April 3, 2017
49.6K
Bone formation by human umbilical cord perivascular cells
Sohtaro Kajiyama1, Yuko Ujiie1, Sumio Nishikawa1
1School of Dental Medicine, Tsurumi University, Tsurumi-ku, Yokohama, Kanagawa, Japan.
Journal of Biomedical Materials Research. Part A
|February 14, 2015
Summary
Human umbilical perivascular cells (HUCPVCs) show promise for bone tissue engineering, demonstrating significant bone repair in vivo. In vitro tests did not accurately predict these positive outcomes, suggesting HUCPVCs alone are effective without additional bone marrow mesenchymal stromal cell conditioning.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Cell Biology
Background:
- Mesenchymal stromal cells (MSCs) are crucial for bone tissue engineering.
- Identifying alternative MSC sources is vital for clinical applications.
- Conditioned medium (CM) from bone marrow (BM) MSCs may enhance osteogenesis.
Purpose of the Study:
- To evaluate human umbilical perivascular cells (HUCPVCs) as an alternative MSC source for bone regeneration.
- To investigate the osteogenic potential of HUCPVCs, alone and with BM-MSC CM.
- To compare in vitro findings with in vivo bone repair outcomes.
Main Methods:
- HUCPVCs and BM-MSCs were cultured in vitro.
- Osteogenic gene expression and alkaline phosphatase activity were assessed.
- A rat calvarial defect model with collagen sponge scaffolds was used for in vivo evaluation.
Main Results:
- In vitro assays showed limited osteogenic potential in HUCPVCs compared to BM-MSCs.
- HUCPVCs significantly enhanced bone repair in vivo compared to controls.
- BM-MSC CM did not provide an additional osteogenic advantage to HUCPVCs in vivo.
- In vitro results did not correlate with in vivo bone formation efficacy.
Conclusions:
- HUCPVCs are a viable cell source for bone tissue engineering, showing significant in vivo bone repair capabilities.
- Current in vitro assays may not accurately predict the in vivo osteogenic performance of cells like HUCPVCs.
- The use of BM-MSC conditioned medium did not enhance the bone regenerative capacity of HUCPVCs in this study.

